Race Oncology Ltd (RAC)

Sydney
Currency in AUD
1.400
-0.010(-0.71%)
Delayed Data·
RAC Scorecard
Full Analysis
Stock price movements are quite volatile
RAC is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
1.3451.440
52 wk Range
0.9202.090
Key Statistics
Edit
Bid/Ask
1.365 / 1.415
Prev. Close
1.41
Open
1.44
Day's Range
1.345-1.44
52 wk Range
0.92-2.09
Volume
100.77K
Average Volume (3m)
138.67K
1-Year Change
-11.61%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
RAC Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Analysts do not anticipate the company will be profitable this year
Show more

Race Oncology Company Profile

Race Oncology Limited, a clinical stage biopharmaceutical company, focuses on addressing the unmet needs of cancer patients for damaging treatments. The company’s lead product is bisantrene, a small molecule chemotherapeutic that has a clinical history with demonstrated therapeutic benefits in adult and paediatric patients. It is advancing reformulated bisantrene (RC220) to address the unmet need of patients across various oncology indications with a clinical focus on anthracycline combination to deliver cardioprotection and enhanced anticancer activity in solid tumors. The company is also exploring RC220 as a low intensity treatment for acute myeloid leukaemia. In addition, it is investigating the effect of bisantrene on the m6A RNA pathway, following independent research identifying bisantrene as the potent inhibitor of fat mass and obesity-associated protein. The company has collaborations with Astex, City of Hope, MD Anderson, Sheba City of Health, UNC School of Medicine, University of Wollongong, and University of Newcastle. The company was formerly known as Coronado Resources Limited. Race Oncology Limited was incorporated in 2011 and is headquartered in Sydney, Australia.

Compare RAC to Peers and Sector

Metrics to compare
RAC
Peers
Sector
Relationship
P/E Ratio
−32.0x−4.1x−0.5x
PEG Ratio
−0.93−0.030.00
Price/Book
11.8x2.6x2.6x
Price / LTM Sales
46.6x8.5x3.0x
Upside (Analyst Target)
351.8%246.1%54.7%
Fair Value Upside
Unlock11.0%8.4%Unlock

Earnings

Latest Release
Feb 25, 2025
EPS / Forecast
-- / --
Revenue / Forecast
5.25M / --
EPS Revisions
Last 90 days

FAQ

What Is the Race Oncology (RAC) Stock Price Today?

The Race Oncology stock price today is 1.40.

What Stock Exchange Does Race Oncology Trade On?

Race Oncology is listed and trades on the Sydney Stock Exchange stock exchange.

What Is the Stock Symbol for Race Oncology?

The stock symbol for Race Oncology is "RAC."

What Is the Race Oncology Market Cap?

As of today, Race Oncology market cap is 243.22M.

What Is Race Oncology's Earnings Per Share (TTM)?

The Race Oncology EPS (TTM) is -0.05.

From a Technical Analysis Perspective, Is RAC a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.